@article{53fd5befd9e049198312a255b16eae2c,
title = "“Sticky” Issues for Adherence in Secondary Prevention",
keywords = "behavioral science, comparative effectiveness, medication adherence, patient engagement, secondary prevention",
author = "Peterson, {Eric D.} and Navar, {Ann Marie}",
note = "Funding Information: Dr. Navar is supported by National Heart, Lung, and Blood Institute grant K01HL133416. Dr. Peterson has received research funding from AstraZeneca, Janssen Pharma, Merck & Co., Regeneron Pharm, Genentech, Eli Lilly, and Sanofi; and has received consulting support from Janssen, Merck and Co., Bayer, Daiichi-Sankyo, and Sanofi. Dr. Navar has been a consultant for Amgen, Sanofi, and Regeneron; and has received fees for research consulting from Amgen and Sanofi. ",
year = "2017",
month = sep,
day = "26",
doi = "10.1016/j.jacc.2017.07.788",
language = "English (US)",
volume = "70",
pages = "1555--1557",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "13",
}